H. Inano et al., CHEMOPREVENTION BY DIETARY DEHYDROEPIANDROSTERONE AGAINST PROMOTION PROGRESSION PHASE OF RADIATION-INDUCED MAMMARY TUMORIGENESIS IN RATS/, Journal of steroid biochemistry and molecular biology, 54(1-2), 1995, pp. 47-53
When pregnant rats received whole body irradiation with 260 cGy gamma-
ray at day 20 of pregnancy, and were then implanted with a diethylstil
bestrol (DES) pellet for an experimental period of 1 year under feedin
g of a control diet, a high incidence (96.2%) of mammary tumors was ob
served. Administration of dietary 0.6% dehydroepiandrosterone (DHEA) t
ogether with DES implantation significantly decreased the incidence (3
5.0%) of mammary tumors. The first appearance of palpable tumors in th
e DHEA-fed group was 4.5 months later than that in the control group.
For clarification of the mechanism of the chemopreventive action, we m
easured hormone levels in the serum of DHEA-fed rats. In the DHEA diet
rats, the concentration of estradiol-17 beta exceeded, by approximate
ly 6-fold, that in the control rats, while the levels of progesterone
and prolactin were decreased by 30 and 45%, respectively. Interestingl
y, DHEA feeding prevented DES-induced hypertrophy of pituitary glands
and DES-induced high level of prolactin in pituitary glands detected b
y immunohistochemical studies, but stimulated the development of mamma
ry glands more than that in control rats treated with DES alone. These
findings suggest that DHEA has a potent preventive activity against t
he promotion/progression phase of radiation-induced mammary tumorigene
sis. The mechanism of chemoprevention by change of endocrinological en
vironment is discussed.